Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Inovio First to Advance Lassa Fever Candidate Vaccine Into a Clinical Trial 2019-05-21 21:00
First Sublingual Ketamine Drug for Treatment of Acute Pain to be Evaluated in End-of-Phase 2 Meeting with FDA 2019-05-21 18:11
Merck Joins TRANSVAC2 Program to Advance Vaccine Development and Manufacturing 2019-05-20 20:00
Kazia Enters Clinical Collaboration for Metastatic Brain Cancer with Alliance for Clinical Trials in Oncology 2019-05-20 11:41
Bridge Biotherapeutics Announces Data Presentation from First-in-Human Study of BBT-877 for Idiopathic Pulmonary Fibrosis 2019-05-20 08:38
Chairman and Managing Director of AMN Life Science Honored at the 10th Asia Pacific Entrepreneurship Awards 2019 2019-05-17 16:52
ChemPartner and Berkeley Lights Take Next Step in B Cell Antibody Discovery Collaboration 2019-05-16 23:00
Apollo Proton Cancer Centre, Chennai performs India's First Total Marrow Irradiation Procedure 2019-05-15 22:46
Hangzhou attracts RMB1.5 billion investments in bio-pharmaceutical projects in Q1 2019-05-15 20:56
NeuClone to Initiate Phase I Clinical Trial of Stelara (Ustekinumab) Biosimilar, the Second Biosimilar from the 10-product Portfolio with Serum Institute 2019-05-15 20:13
China Pharma Holdings, Inc. Reports First Quarter 2019 Financial Results 2019-05-15 18:00
Ping An Good Doctor and Wyeth Reached Strategic Cooperation 2019-05-15 15:20
FDA Approves BAVENCIO® (avelumab) plus Axitinib Combination for Patients with Advanced Renal Cell Carcinoma 2019-05-15 08:25
Pneuma Respiratory and Leads Biolabs, Inc. Announce Partnership 2019-05-15 07:53
Sekisui Diagnostics Invests $1.9 million in Microbial Biopharma CDMO Business 2019-05-15 03:11
Peritech Pharma Granted Patents for China and Russia 2019-05-14 08:55
Frost & Sullivan Publishes Annual Update on BioLineRx 2019-05-13 23:46
China Biologic Reports Financial Results for the First Quarter of 2019 2019-05-11 04:30
NeuroVive's IND for Clinical Development of NeuroSTAT Approved by FDA 2019-05-10 15:05
Ally Bridge Group Leads Pulmonx's $65 Million Financing, Further Strengthening Its Global Medtech Franchise 2019-05-10 10:05
1 317 318 319 320 321 401